The global trimebutine market is supported by demand for medicines that address abdominal pain and intestinal spasms. Trimebutine's role in managing gastrointestinal motility-related symptoms makes it relevant to selected treatment approaches for digestive conditions. The trimebutine market size is expected to reach US$ 272.14 million by 2034 from US$ 161.21 million in 2025, registering a CAGR...